683 Capital Management, LLC Adamis Pharmaceuticals Corp Transaction History

683 Capital Management, LLC

  • $1.1 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020
SELL
$0.51 - $1.26 $988,800 - $2.44 Million
-1,938,825 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$0.7 - $1.46 $762,177 - $1.59 Million
1,088,825 Added 128.1%
1,938,825 $1.37 Million
Q3 2018

Nov 14, 2018
BUY
$2.25 - $4.8 $1.91 Million - $4.08 Million
850,000 New
850,000 $2.98 Million

About Adamis Pharmaceuticals Corp

ADMP Quotes by TradingView
  • Ticker ADMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 149,983,008
  • Market Cap $73.5M
  • Description
  • Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...
More about ADMP
Track This Portfolio

Track 683 Capital Management, LLC Portfolio

Follow 683 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 683 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 683 Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email